About Us

CEORoadshow .com
is the premier source of original and syndicated streaming broadcast interviews of Chief Executive Officers of publically traded companies on the Nasdaq, AMEX, and OTCQX and Small Cap Exchanges. We seek to introduce investors to the next big thing by bringing the investor right into the boardroom and hearing the story from the CEO himself.

CEORoadshow.com’s programming is distributed to millions of on-line investors at over 350 financial web sites as well as to more than 5,000 portfolio managers, buy-side analysts and traders at more than 1,500 North American institutions. Content is also disseminated to over 5,000 investment research professionals representing over 275 institutions. All CEORoadshow content is copyrighted to protect our licensing partners.
Please Read Our Disclaimer

Featured Company

Apricus Biosciences, Inc. (Nasdaq:APRI)

SAN DIEGO, Aug. 11, 2011 (GLOBE NEWSWIRE) – Apricus Biosciences, Inc. (“Apricus Bio” or the “Company”) (Nasdaq:APRI) (http://www.apricusbio.com) announced today that Chairman, President and Chief Executive Officer, Dr. Bassam Damaj, was interviewed recently by the CEO Roadshow financial network (http://www.ceoroadshow/). During the interview, Dr. Damaj reported on plans for the Company’s pipeline, including the proposed commercialization in Canada and Europeof Vitaros®, a topical treatment for erectile dysfunction. Disclaimer

December 18, 2011 8:40 PMWatch now

Copyright © 2012 CEO Roadshow All Rights Reserved.    Terms of Use  •  Privacy Policy  •  Site Map

Viestly
CEORoadshow.com is a compensated financial public relations company which is committed to producing the highest-quality insight and analysis of penny stocks, emerging technology stocks, small cap stocks and helping investors make informed decisions. Trade stocks Jim Cramer style.